prednisolone has been researched along with MELAS in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We here reported the clinical course and therapeutic details of a 16-year-old girl with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) who had had five stroke-like episodes (two episodes were clinically mild, while the three subsequent episodes were severe)." | 7.72 | Beneficial effect of L-arginine for stroke-like episode in MELAS. ( Kubota, M; Momoi-Yoshida, M; Mori, M; Sakakihara, Y; Yamagata, T, 2004) |
| "Therefore, the overlapping syndrome of chronic progressive external ophthalmoplegia in the MELAS syndrome is considered in this case." | 5.29 | CPEO and carnitine deficiency overlapping in MELAS syndrome. ( Chen, HL; Chuang, YH; Hsu, CC; Huang, HL; Jong, HJ; Lee, HC; Pang, CY; Shen, YY; Tsai, JL; Wei, YH, 1995) |
| "We here reported the clinical course and therapeutic details of a 16-year-old girl with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) who had had five stroke-like episodes (two episodes were clinically mild, while the three subsequent episodes were severe)." | 3.72 | Beneficial effect of L-arginine for stroke-like episode in MELAS. ( Kubota, M; Momoi-Yoshida, M; Mori, M; Sakakihara, Y; Yamagata, T, 2004) |
| "Therefore, the overlapping syndrome of chronic progressive external ophthalmoplegia in the MELAS syndrome is considered in this case." | 1.29 | CPEO and carnitine deficiency overlapping in MELAS syndrome. ( Chen, HL; Chuang, YH; Hsu, CC; Huang, HL; Jong, HJ; Lee, HC; Pang, CY; Shen, YY; Tsai, JL; Wei, YH, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HS | 1 |
| Lee, JH | 1 |
| Lee, SH | 1 |
| Lee, YM | 1 |
| Kubota, M | 1 |
| Sakakihara, Y | 1 |
| Mori, M | 1 |
| Yamagata, T | 1 |
| Momoi-Yoshida, M | 1 |
| Hsu, CC | 1 |
| Chuang, YH | 1 |
| Tsai, JL | 1 |
| Jong, HJ | 1 |
| Shen, YY | 1 |
| Huang, HL | 1 |
| Chen, HL | 1 |
| Lee, HC | 1 |
| Pang, CY | 1 |
| Wei, YH | 1 |
3 other studies available for prednisolone and MELAS
| Article | Year |
|---|---|
Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note.
Topics: Femur Head Necrosis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; MELAS Syndrome; Pred | 2018 |
Beneficial effect of L-arginine for stroke-like episode in MELAS.
Topics: Adolescent; Arginine; Brain; Brain Ischemia; Drug Therapy, Combination; Energy Metabolism; Female; G | 2004 |
CPEO and carnitine deficiency overlapping in MELAS syndrome.
Topics: Adult; Atrophy; Biopsy; Brain; Carnitine; Cerebral Cortex; DNA, Mitochondrial; Female; Humans; MELAS | 1995 |